About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
HISTORICAL VOLUME
Historical
Volume
Gland Pharma Ltd.
BSE Code
543245
ISIN Demat
INE068V01023
Book Value
608.43
NSE Code
GLAND
Dividend Yield %
0.91
Market Cap
327511.06
P/E
28.83
EPS
68.96
Face Value
1
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Date
Open Price(Rs.)
High Price(Rs.)
Low Price(Rs.)
Close Price(Rs.)
Volume
Turnover
17-Sep-2025
2025.00
2041.95
1973.00
1987.85
4309
8624517
16-Sep-2025
2009.95
2049.55
2009.95
2021.30
8824
17974866
15-Sep-2025
2010.10
2043.70
1997.00
2015.40
4284
8647107
12-Sep-2025
1984.95
2027.90
1954.50
2020.85
9640
19332910
11-Sep-2025
1910.15
1985.95
1905.55
1965.55
13724
26765105
10-Sep-2025
1944.95
1957.05
1888.35
1903.30
2565
4922233
09-Sep-2025
1849.25
1929.00
1849.25
1919.35
3170
6056799
08-Sep-2025
1900.00
1907.55
1856.95
1868.60
4529
8484318
05-Sep-2025
1886.05
1939.00
1879.20
1893.45
5251
10025964
04-Sep-2025
1877.65
1900.00
1862.65
1887.25
5278
9953751
03-Sep-2025
1873.85
1893.35
1864.70
1879.10
4066
7655991
02-Sep-2025
1870.55
1891.50
1860.40
1864.55
2017
3780938
01-Sep-2025
1885.00
1894.40
1849.00
1868.80
3067
5728033
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.